| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 82,119 | 73,614 | 63,268 | 81,352 | | Cost of Revenue | 70,267 | 63,124 | 54,276 | 69,793 | | | Gross Profit | 11,852 | 10,490 | 8,992 | 11,559 | | | Operating Expenses | | Research Development | 2,310 | 2,355 | 2,348 | 2,315 | | Selling General and Administrative | 6,904 | 5,820 | 5,233 | 4,585 | | Non Recurring |
-
| 5 | (5) | 4,928 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,637 | 2,310 | 1,416 | (269) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,532 | 640 | 381 | 853 | | Earnings Before Interest And Taxes | 3,181 | 2,950 | 1,797 | 584 | | Interest Expense | 83 | 70 | 5 | 6 | | Income Before Tax | 3,098 | 2,880 | 1,792 | 578 | | Income Tax Expense | 400 | 300 | 201 | (195) | | Minority Interest |
-
|
-
|
-
| (78) | | | | Net Income From Continuing Ops | 3,685 | 2,580 | 1,591 | 695 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,283 | 2,580 | 1,591 | 695 | | Preferred Stock And Other Adjustments | 83 | (47) | (36) |
-
| | | Net Income Applicable To Common Shares | $3,366 | $2,533 | $1,555 | $695 |
|
0.51% Nasdaq 
Income Statement
